Literature DB >> 3421974

Purification of carboxyl ester lipase from human pancreas and the amino acid sequence of the N-terminal region.

C S Wang1.   

Abstract

A procedure for the purification of carboxyl ester lipase from human pancreas has been developed. The determined N-terminal 10 amino acid residues of the purified enzyme, NH2-Ala-Lys-Leu-Gly-Ala-Val-Tyr-Thr-Glu-Gly, was identical to the terminal of human milk bile salt-activated lipase. The human pancreatic carboxyl ester lipase has an apparent molecular weight slightly smaller than that of human milk bile salt-activated lipase (105,000 vs 125,000) as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Thus, it is possible that the human pancreatic carboxyl ester lipase and human milk bile salt-activated lipase could be produced by the same gene by a different splice or post-translational modification. Alternatively, they could simply be the products of two closely related but separate genes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421974     DOI: 10.1016/s0006-291x(88)80588-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Localization of carboxyl ester lipase in human pituitary gland and pituitary adenomas.

Authors:  Stefano La Rosa; Davide Vigetti; Claudia Placidi; Giovanna Finzi; Silvia Uccella; Moira Clerici; Barbara Bartolini; Ileana Carnevali; Marco Losa; Carlo Capella
Journal:  J Histochem Cytochem       Date:  2010-06-21       Impact factor: 2.479

2.  Acyl-chain specificity of human milk bile-salt-activated lipase.

Authors:  C S Wang
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

3.  The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.

Authors:  Stefano La Rosa; Francesca Franzi; Silvia Marchet; Giovanna Finzi; Moira Clerici; Davide Vigetti; Anna Maria Chiaravalli; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2008-12-09       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.